Popular Articles

Additional Phase II Data Demonstrate Improvement In Reported Symptoms In Patients Who Still Experience GERD Symptoms Despite PPI Therapy
Adding AZD3355, a novel GABAB receptor agonist, to a proton pump inhibitor (PPI) in patients with Gastroesophageal Reflux Disease (GERD), resulted in a 35% reduction in the mean total number of reflux episodes 0-24 hours after dose, compared with placebo.[i] These data were presented at the Digestive Diseases Week annual meeting (DDW®, 30 May - 4 June, Chicago).

FDA Approves Vaccine For Seasonal Influenza
The US Food and Drug Administration (FDA) announced yesterday that it has approved a vaccine for 2009-2010 seasonal influenza in the United
News of the day
GTCbio Announces Its 4th Annual Assay Development And Screening Technologies Conference Taking Place On June 8-9, 2009 In San Francisco
GTCbio Announces 4th Annual Assay Development and Screening Conference taking place June 8-9, 2009. As compounds derived from high throughput screening increasingly find their way into clinical trials, drug screening has become widely accepted as a critical step in the drug discovery process. After more than a decade of rapid growth, tremendous progress has been made in assay technology, laboratory automation, and informatics. These technological developments have not only facilitated a drastic increase in throughput and efficiency in drug screening, but have also provided novel solutions in other areas of drug discovery and development. As screening has also become prominent in biological research, screening facilities have become increasingly popular in academic institutions.
Cardiovascular

Anti-Smoking Initiative Targets China's Medical Professionals

China Daily explores how a new anti-smoking initiative in China targets the country"s medical professionals. According to the newspaper, "China is the world"s largest tobacco producer and consumer," with "350 million smokers, plus 450 million people exposed to second-hand smoke." Annually, 1 million deaths are smoking-related, according to China"s Ministry of Health. Through the five-year-long "China Medical Tobacco Initiative" -- funded by the Bill & Melinda Gates Foundation, supported by the Ministry of Health, and coordinated by the China Medical Board (CMB) -- 13 medical universities and their affiliated hospitals will work to implement smoke-free campuses and hospitals, incorporate tobacco control into medical education and improve the hospital services available for patients who want to quit smoking. The newspaper writes, "International evidence shows that the medical profession is a critical and powerful force in tobacco control. In China, however, studies show more than 50 percent of male doctors smoke. Smoking by doctors not only goes against their "health ambassador" image, but also affects their credibility when they attempt to help patients, says Professor [Lincoln] Chen" of the CMB. The program"s ultimate goal is a smoke-free China, according to Chen (Ru, 7/29). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):